Clinical characteristics and risk factors for SARS-CoV-2 infection in pregnant women attending a third level reference center in Mexico City


Por: Hernández-Cruz R.G., Sánchez-Cobo D., Acevedo-Gallegos S., Helguera-Repetto A.C., Rodriguez-Bosch M.R., Ramirez-Santes V.H., Villegas-Mota I., Cardona-Pérez A., Cortes-Bonilla M., Irles C., Mateu-Rogell P., Villanueva-Calleja J., Villavicencio Carrisoza O., Estrada-Gutiérrez G., Espino-Y-sosa S., Torres-Torres J., Martinez-Portilla R.J.

Ahead of Print: 1 ene 2021
Resumen:
Background: COVID-19 symptoms vary widely among pregnant women. We aimed to assess the most frequent symptoms amongst pregnant women with SARS-CoV-2 infection in a tertiary hospital in Mexico City. Methods: A cross-sectional study of pregnant women attending the National Institute of Perinatology in Mexico City was performed. All women who attended the hospital, despite their symptoms, were tested for SARS-CoV-2. A multivariate-age-adjusted logistic regression was used to assess the association between the main outcome and each characteristic of the clinical history. Results: A total of 1880 women were included in the data analysis. Among all women, 30.74% (n = 578) had a positive PCR for SARS-CoV-2 from which 2.7 (n = 50) were symptomatic. Symptoms associated with a positive PCR result were headache (p=.01), dyspnea (p=.043), and myalgia (p=.043). Conclusions: At universal screening for SARS-CoV-2, one-third of the population had a positive result, while those symptoms associated with a positive PCR were headache, dyspnea, and myalgia. © 2021 Informa UK Limited, trading as Taylor & Francis Group.

Filiaciones:
Hernández-Cruz R.G.:
 National Institute of Perinatology, Mexico City, Mexico

Sánchez-Cobo D.:
 National Institute of Perinatology, Mexico City, Mexico

Acevedo-Gallegos S.:
 National Institute of Perinatology, Mexico City, Mexico

Helguera-Repetto A.C.:
 National Institute of Perinatology, Mexico City, Mexico

Rodriguez-Bosch M.R.:
 National Institute of Perinatology, Mexico City, Mexico

Ramirez-Santes V.H.:
 National Institute of Perinatology, Mexico City, Mexico

Villegas-Mota I.:
 National Institute of Perinatology, Mexico City, Mexico

Cardona-Pérez A.:
 National Institute of Perinatology, Mexico City, Mexico

Cortes-Bonilla M.:
 National Institute of Perinatology, Mexico City, Mexico

Irles C.:
 National Institute of Perinatology, Mexico City, Mexico

Mateu-Rogell P.:
 National Institute of Perinatology, Mexico City, Mexico

Villanueva-Calleja J.:
 National Institute of Perinatology, Mexico City, Mexico

Villavicencio Carrisoza O.:
 National Institute of Perinatology, Mexico City, Mexico

Estrada-Gutiérrez G.:
 National Institute of Perinatology, Mexico City, Mexico

Espino-Y-sosa S.:
 National Institute of Perinatology, Mexico City, Mexico

Torres-Torres J.:
 National Institute of Perinatology, Mexico City, Mexico

 Fetal Medicine Research Center, BCNatal–Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clinic and Hospital Sant Joan de Deu), Institut Clínic de Ginecologia, Obstetricia i Neonatologia, Universitat de Barcelona, Barcelona, Spain

Martinez-Portilla R.J.:
 National Institute of Perinatology, Mexico City, Mexico

 Fetal Medicine Research Center, BCNatal–Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clinic and Hospital Sant Joan de Deu), Institut Clínic de Ginecologia, Obstetricia i Neonatologia, Universitat de Barcelona, Barcelona, Spain
ISSN: 14767058
Editorial
TAYLOR & FRANCIS LTD, 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND, Reino Unido
Tipo de documento: Article
Volumen: Número:
Páginas:
WOS Id: 000633235400001
ID de PubMed: 33771080